-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - ESRD, ESRD encounter, dialysis procedure, and dependence on dialysis
as exclusions: Chronic kidney disease … The ACC states, “People with chronic kidney disease are at higher risk of
side effects from lipid medications … further
states, “People with chronic kidney disease are at higher risk of side effects from lipid … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … www.acc.org/latest-in-cardiology/articles/2016/05/31/13/00/lipid-management-guidelines-for-adults-with-chronic-kidney-disease
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - Chronic kidney disease has been associated with an increased risk of
CVD.14 However, multiple studies … The ACC
states, “People with chronic kidney disease are at higher risk of side effects from
lipid medications … further
states “People with chronic kidney disease are at higher risk of side effects from lipid
medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … KDIGO Clinical
Practice Guideline for Lipid Management in Chronic Kidney Disease.
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
January 01, 2023 - Chronic kidney disease has been associated with an increased risk of
CVD.13 However, multiple studies … The ACC
states, “People with chronic kidney disease are at higher risk of side effects from
lipid medications … further
states “People with chronic kidney disease are at higher risk of side effects from lipid
medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … KDIGO Clinical
Practice Guideline for Lipid Management in Chronic Kidney Disease.
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
January 01, 2003 - N18.2 Chronic kidney disease, stage 2 (mild) 313863 Bisacodyl 5 MG Rectal Suppository … N18.3 Chronic kidney disease, stage 3 (moderate) 314087 Magnesium Hydroxide 240 MG/ML Oral Suspension … N18.4 Chronic kidney disease, stage 4 (severe) 314113 Magnesium Oxide 200 MG Oral Tablet … N18.5 Chronic kidney disease, stage 5 317055 Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG … kidney disease, unspecified 343017 Mineral Oil 1000 MG/ML Oral Solution
Hepatic Dysfunction
-
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
04/19/2017
Time
01:00 – 3:00 PM EST
AGENDA
· Welcome
· Brief Overview of Existing CDS Connect Artifacts
· Clarify Logic Details for USPTF-related Artifacts
· Discuss Best Approach for Transforming eCQM Specifications into CDS Logic
· Next Steps an…